Sarah Viall

Incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data

Kimberly A. Chapman, Gwendolyn Gramer, Sarah Viall et al. · Molecular Genetics and Metabolism Reports · 2018 · 57 citations · Full text

Incorporation of Second-Tier Biomarker Testing Improves the Specificity of Newborn Screening for Mucopolysaccharidosis Type I

Dawn Peck, Jean M. Lacey, Amy White et al. · International Journal of Neonatal Screening · 2020 · 42 citations · Full text

Population-Based Screening of Newborns: Findings From the NBS Expansion Study (Part One)

Amy Brower, Kee Chan, Marc S. Williams et al. · Frontiers in Genetics · 2022 · 21 citations · Full text

Neonatology, Nbs Expansion, Early Diagnosis +22

Newborn screening for Fabry disease in Oregon: Approaching the iceberg of <scp>A143T</scp> and variants of uncertain significance

Sarah Viall, Anna Dennis, Amy Yang · American Journal of Medical Genetics Part C Seminars in Medical Genetics · 2022 · 14 citations

Genetic Testing, Uncertain Significance, Genetics +22

Mucopolysaccharidosis type I newborn screening: Importance of second tier testing for ethnically diverse populations

Kerri Bosfield, Debra S. Regier, Sarah Viall et al. · American Journal of Medical Genetics Part A · 2020 · 12 citations